Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Natasa Snoj"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Expert Review of Anticancer Therapy. 8:1883-1890
Trastuzumab, a humanized monoclonal antibody directed against HER2, used alone or in combination with chemotherapy, has shown significant clinical benefit in improving survival in the metastatic setting, as well as halving the recurrence rate and imp
Publisher Summary This chapter provides an overview of the molecular biology of breast cancer. Breast cancer is the most common cancer among women with a yearly incidence of 109.8 per 100,000 individuals. It is also the second leading cause of cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd601b9d8cf6fa7c40e389ea283ab1c8
https://doi.org/10.1016/b978-0-12-374418-0.00026-8
https://doi.org/10.1016/b978-0-12-374418-0.00026-8
Autor:
Dara L. Aisner, M. Michael Barmada, Philippe L. Bedard, David O. Beenhouwer, Jaideep Behari, Maria Berdasco, Carlise R. Bethel, Joseph R. Biggs, Grant C. Bullock, Sheldon M. Campbell, Wai-Yee Chan, William B. Coleman, Mattia Cremona, Angelo M. De Marzo, Phuong Dinh, Vladislav Dolgachev, Virginia Espina, Manel Esteller, Carol F. Farver, William K. Funkhouser, Avrum I. Gotlieb, Robert F. Hevner, W. Edward Highsmith, C. Dirk Keene, Wolfgang Kemmner, Nigel S. Key, Hong Kee Lee, Joel A. Lefferts, John J. Lemasters, Markus M. Lerch, Lance A. Liotta, Alessandra Luchini, Amber Chang Liu, Karen Lu, Nicholas W. Lukacs, Alice D. Ma, Julia Mayerle, Kara A. Mensink, Samuel Chi-ho Mok, Satdarshan (Paul) Singh Monga, Thomas J. Montine, Jason H. Moore, Amy K. Mottl, Karl Munger, Zoltan Nagymanyoki, William G. Nelson, Carla Nester, Margret D. Oethinger, Alan L.-Y. Pang, Emanuel F. Petricoin, Ashley G. Rivenbark, C. Harker Rhodes, Tara C. Rubinas, Reinhold Schafer, Matthias Sendler, Antonia R. Sepulveda, Christine Sers, Lawrence M. Silverman, Natasa Snoj, Joshua A. Sonnen, Christos Sotiriou, Gregory J. Tsongalis, Vesarat Wessagowit, David C. Whitcomb, Kwong-kwok Wong, Dani S. Zander, Dong-Er Zhang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c38787e5381f7262ddb81b93a83e5a1
https://doi.org/10.1016/b978-0-12-374418-0.00039-6
https://doi.org/10.1016/b978-0-12-374418-0.00039-6
Publikováno v:
Breast cancer research, 11 (1
Breast Cancer Research : BCR
Breast Cancer Research : BCR
Through the use of surrogate markers of efficacy, neoadjuvant studies may facilitate the implementation of new treatments into clinical practice. However, disease-free survival is the current standard outcome endpoint for registration of a novel trea
Publikováno v:
Current opinion in oncology. 20(6)
Purpose of review Hormone receptor positive breast cancer is responsible for the majority of breast cancer deaths. The risk for disease recurrence that is lower in the first 5 years after primary treatment than for hormone receptor negative breast ca
Publikováno v:
Onkologija, Vol 15, Iss 2, Pp 106-109 (2011)
Hormonsko zdravljenje s kastracijo je v začetku navadno učinkovito pri večini bolnikov z razsejanim rakom prostate, vendar bolezen čez čas neizbežno napreduje. Docetaksel v kombinaciji s prednizonom predstavlja standardno zdravljenje v prvi lin
Externí odkaz:
https://doaj.org/article/aff08e5ddd5f463eb610f57ffbf8792f
Autor:
Boštjan Šeruga, Nataša Snoj Šarvari
Publikováno v:
Onkologija, Vol 12, Iss 1, Pp 64-65 (2008)
Ni abstrakta.
Externí odkaz:
https://doaj.org/article/3fbdd221ca2641d7ba20a4852e08c0f8